Significant increase in volume has been observed in Sun Pharma Advanced Research Company Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The NSE observed an unusual and significant rise in trading volume in shares of Sun Pharma Advanced Research Company (SPARC) and has formally written to the company asking for an explanation, as is standard under exchange surveillance norms. The company's response is still awaited, so no clarification or material information has been shared with the public yet. Until the company responds, the exact reason behind the sudden volume spike remains unknown. Investors should treat this as a regulatory watch notice and monitor for any further disclosure from the company.
This is a routine exchange surveillance notice and not a negative action — it simply means regulators are checking if there is undisclosed price-sensitive information driving the volume. The stock could stay volatile until the company responds; investors should wait for clarity before making decisions.